Taken together, we hypothesize that the lack of p53 transcriptional activity in AsiDNA-treated p53 proficient tumour cells is likely due to the inability of p53 to connect to the AsiDNATM/DNA-PK complexes. Here, PRKDC is linked to neoplasm.